MCA-Embolism Local fibrynolytic intervention Trial "MELT"

Suspended

Phase N/A Results

Summary of Purpose

To determine the clinical efficacy and safety of intra-arterial Urokinase in patients with acute MCA stroke of less than 6 hours duration.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 April 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • The Japanese Ministry of Health, Welfare, and Labor

Trial Design

Prospective, randomized, controlled, multicenter, open-label clinical trial with blinded follow-up.

Contacts

Not available